Neurocrine Biosciences (NBIX) had the highest return between August 1, 2014 and January 31, 2015 by a large-cap US stock, returning 148%.
| ASSET | DATE | % RETURN |
|---|---|---|
Neurocrine Biosciences (NBIX) | 8/1/2014 - 1/31/2015 | 148.05% |
Axon Enterprise (AXON) | 8/1/2014 - 1/31/2015 | 124.9% |
Ionis Pharmaceuticals (IONS) | 8/1/2014 - 1/31/2015 | 119.02% |
Paycom Soft (PAYC) | 8/1/2014 - 1/31/2015 | 103.82% |
Monster Beverage (MNST) | 8/1/2014 - 1/31/2015 | 82.02% |
EXACT Sciences (EXAS) | 8/1/2014 - 1/31/2015 | 74.65% |
Alnylam Pharmaceuticals (ALNY) | 8/1/2014 - 1/31/2015 | 73.25% |
Lululemon Athletica (LULU) | 8/1/2014 - 1/31/2015 | 71.25% |
Incyte (INCY) | 8/1/2014 - 1/31/2015 | 66.62% |
Genmab A-S (GMAB) | 8/1/2014 - 1/31/2015 | 66.6% |
Skyworks Solutions (SWKS) | 8/1/2014 - 1/31/2015 | 65.85% |
MACOM Technology Solutions (MTSI) | 8/1/2014 - 1/31/2015 | 63.53% |
Electronic Arts (EA) | 8/1/2014 - 1/31/2015 | 63.52% |
Southwest Airlines (LUV) | 8/1/2014 - 1/31/2015 | 60.7% |
Advanced Drainage Systems (WMS) | 8/1/2014 - 1/31/2015 | 60.63% |
Biomarin Pharmaceutical (BMRN) | 8/1/2014 - 1/31/2015 | 59.2% |
DexCom (DXCM) | 8/1/2014 - 1/31/2015 | 58.48% |
Palo Alto Networks (PANW) | 8/1/2014 - 1/31/2015 | 57.26% |
United Therapeutics (UTHR) | 8/1/2014 - 1/31/2015 | 55.7% |
Manhattan Associates (MANH) | 8/1/2014 - 1/31/2015 | 52.77% |
Burlington Stores (BURL) | 8/1/2014 - 1/31/2015 | 52.24% |
Centene (CNC) | 8/1/2014 - 1/31/2015 | 51.38% |
Gold Fields Ltd ADR (GFI) | 8/1/2014 - 1/31/2015 | 50.38% |
United Airlines (UAL) | 8/1/2014 - 1/31/2015 | 49.18% |
Broadcom (AVGO) | 8/1/2014 - 1/31/2015 | 48.21% |
Large-cap stocks are treated as having a market cap of $10B+.
